RNAZ TRANSCODE THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Stockholder Meeting On February 25, 2025, Transcode Therapeutics held a special meeting where stockholders approved two proposals regarding the issuance and adjustments of shares related to Series C and D Warrants, with 130,226 votes for and 51,288 against Proposal One. Proposal Two, to adjourn the meeting if needed, was also approved with 143,639 votes for and 38,206 against.Get access to all SEC 8-K filings of the TRANSCODE THERAPEUTICS INC